Search

Anna Pagonakis

Examiner (ID: 6985)

Most Active Art Unit
1628
Art Unit(s)
1614, 4173, 1609, 1628, OPET
Total Applications
1238
Issued Applications
444
Pending Applications
73
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6296390 [patent_doc_number] => 20100160442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'FORMULATIONS FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/510969 [patent_app_country] => US [patent_app_date] => 2009-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27934 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160442.pdf [firstpage_image] =>[orig_patent_app_number] => 12510969 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/510969
FORMULATIONS FOR CANCER TREATMENT Jul 27, 2009 Abandoned
Array ( [id] => 6374606 [patent_doc_number] => 20100075933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'INJECTABLE COMPOSITIONS OF VITAMIN D COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/509697 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075933.pdf [firstpage_image] =>[orig_patent_app_number] => 12509697 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/509697
INJECTABLE COMPOSITIONS OF VITAMIN D COMPOUNDS Jul 26, 2009 Abandoned
Array ( [id] => 10613766 [patent_doc_number] => 09333194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor' [patent_app_type] => utility [patent_app_number] => 12/504823 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3917 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12504823 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/504823
Use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor Jul 16, 2009 Issued
Array ( [id] => 5316507 [patent_doc_number] => 20090281105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'RADIOTHERAPY ENHANCER' [patent_app_type] => utility [patent_app_number] => 12/505016 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6991 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281105.pdf [firstpage_image] =>[orig_patent_app_number] => 12505016 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/505016
RADIOTHERAPY ENHANCER Jul 16, 2009 Abandoned
Array ( [id] => 6590550 [patent_doc_number] => 20100130478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'SUSTAINED RELEASE FORMULATIONS OF PSYCHOACTIVE DRUGS' [patent_app_type] => utility [patent_app_number] => 12/500852 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9072 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130478.pdf [firstpage_image] =>[orig_patent_app_number] => 12500852 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/500852
Sustained release formulations of psychoactive drugs Jul 9, 2009 Issued
Array ( [id] => 6142177 [patent_doc_number] => 20110129467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'THERAPEUTIC COMBINATION COMPRISING AN AURORA KINASE INHIBITOR AND ANTIPROLIFERATIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 13/054868 [patent_app_country] => US [patent_app_date] => 2009-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4043 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129467.pdf [firstpage_image] =>[orig_patent_app_number] => 13054868 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/054868
THERAPEUTIC COMBINATION COMPRISING AN AURORA KINASE INHIBITOR AND ANTIPROLIFERATIVE AGENTS Jul 8, 2009 Abandoned
Array ( [id] => 6016839 [patent_doc_number] => 20110224223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'MTOR Modulators and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/003562 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 42102 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224223.pdf [firstpage_image] =>[orig_patent_app_number] => 13003562 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/003562
MTOR Modulators and Uses Thereof Jul 7, 2009 Abandoned
Array ( [id] => 6000956 [patent_doc_number] => 20110117212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'THERAPEUTIC COMBINATION COMPRISING AN AURORA KINASE INHIBITOR AND AN ANTINEOPLASTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/054646 [patent_app_country] => US [patent_app_date] => 2009-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5336 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117212.pdf [firstpage_image] =>[orig_patent_app_number] => 13054646 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/054646
THERAPEUTIC COMBINATION COMPRISING AN AURORA KINASE INHIBITOR AND AN ANTINEOPLASTIC AGENT Jul 2, 2009 Abandoned
Array ( [id] => 6003278 [patent_doc_number] => 20110118296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Bis-Carbazole DNA Intercalating Agents for Antitumor Therapy' [patent_app_type] => utility [patent_app_number] => 13/002772 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2568 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118296.pdf [firstpage_image] =>[orig_patent_app_number] => 13002772 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/002772
Bis-carbazole DNA intercalating agents for antitumor therapy Jul 1, 2009 Issued
Array ( [id] => 8772506 [patent_doc_number] => 08426462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Ferrocene derivatives with anticancer activity' [patent_app_type] => utility [patent_app_number] => 13/002177 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7276 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13002177 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/002177
Ferrocene derivatives with anticancer activity Jul 1, 2009 Issued
Array ( [id] => 5458708 [patent_doc_number] => 20090258860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'XANTHINE DERIVATIVES FOR THE TREATMENT OF VASCULAR DEPRESSION' [patent_app_type] => utility [patent_app_number] => 12/487782 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10528 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258860.pdf [firstpage_image] =>[orig_patent_app_number] => 12487782 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/487782
XANTHINE DERIVATIVES FOR THE TREATMENT OF VASCULAR DEPRESSION Jun 18, 2009 Abandoned
Array ( [id] => 5368521 [patent_doc_number] => 20090306080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'VETERINARY FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/484950 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7647 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306080.pdf [firstpage_image] =>[orig_patent_app_number] => 12484950 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/484950
VETERINARY FORMULATION Jun 14, 2009 Abandoned
Array ( [id] => 6054526 [patent_doc_number] => 20110110886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'SMALL MOLECULE INHIBITORS OF AUTOTAXIN AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/993397 [patent_app_country] => US [patent_app_date] => 2009-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19287 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110886.pdf [firstpage_image] =>[orig_patent_app_number] => 12993397 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/993397
SMALL MOLECULE INHIBITORS OF AUTOTAXIN AND METHODS OF USE Jun 14, 2009 Abandoned
Array ( [id] => 6026607 [patent_doc_number] => 20110054040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Bicyclic Triterpenoid Iripallidal as a Novel Anti-Glioma and Anti-Neoplastic Therapy' [patent_app_type] => utility [patent_app_number] => 12/809149 [patent_app_country] => US [patent_app_date] => 2009-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2104 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054040.pdf [firstpage_image] =>[orig_patent_app_number] => 12809149 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/809149
Bicyclic Triterpenoid Iripallidal as a Novel Anti-Glioma and Anti-Neoplastic Therapy Jun 10, 2009 Abandoned
Array ( [id] => 5570343 [patent_doc_number] => 20090253721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 12/455750 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16521 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253721.pdf [firstpage_image] =>[orig_patent_app_number] => 12455750 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/455750
Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor Jun 4, 2009 Abandoned
Array ( [id] => 6307160 [patent_doc_number] => 20100069398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Combination therapy' [patent_app_type] => utility [patent_app_number] => 12/479131 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7759 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069398.pdf [firstpage_image] =>[orig_patent_app_number] => 12479131 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/479131
Combination therapy Jun 4, 2009 Abandoned
Array ( [id] => 7515442 [patent_doc_number] => 08039514 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Sulfonamide compounds and use thereof' [patent_app_type] => utility [patent_app_number] => 12/476585 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62117 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039514.pdf [firstpage_image] =>[orig_patent_app_number] => 12476585 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/476585
Sulfonamide compounds and use thereof Jun 1, 2009 Issued
Array ( [id] => 6359352 [patent_doc_number] => 20100087409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID' [patent_app_type] => utility [patent_app_number] => 12/476783 [patent_app_country] => US [patent_app_date] => 2009-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6819 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087409.pdf [firstpage_image] =>[orig_patent_app_number] => 12476783 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/476783
COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID Jun 1, 2009 Abandoned
Array ( [id] => 6327712 [patent_doc_number] => 20100197688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'EPHA4 RTK INHIBITORS FOR TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE DISORDERS AND CANCER' [patent_app_type] => utility [patent_app_number] => 12/473810 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18901 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197688.pdf [firstpage_image] =>[orig_patent_app_number] => 12473810 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/473810
EPHA4 RTK INHIBITORS FOR TREATMENT OF NEUROLOGICAL AND NEURODEGENERATIVE DISORDERS AND CANCER May 27, 2009 Abandoned
Array ( [id] => 6007925 [patent_doc_number] => 20110059956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'THERAPEUTIC AGENT FOR PAIN' [patent_app_type] => utility [patent_app_number] => 12/991179 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4470 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059956.pdf [firstpage_image] =>[orig_patent_app_number] => 12991179 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/991179
THERAPEUTIC AGENT FOR PAIN May 13, 2009 Abandoned
Menu